The effect of method of use of ASA on open heart surgery outcomes

Not Applicable

• Conditions: Condition 1: Coronary artery disease. Condition 2: Coronary artery bypass graft.; Atherosclerotic heart disease; Mechanical complication of coronary artery bypass and valve grafts

• Registration Number: IRCT2015121225488N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

patients with coronary artery disease, scheduled for elective, first time on-pump CABG.
Exclusion criteria: Redo CABG patients; Off pump CABG patients; patients with previous history of taking drugs affecting hemostasis such as warfarin, or patients with deranged hemostatic tests preoperatively.Exceptionally, patients on plavix will be included, provided the drug withheld at least five days before operation; patients with concomitant procedures in addition to CABG, such as mitral valve replacement or repair and so on.These procedures may enhance complexity and duration of surgery, affecting outcomes; patients with unexpected and undesirable complications during operation, for instance aortic rupture following cannulation, in whom outcomes may be altered.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified